Jasper Ridge Partners’s 10x Genomics TXG Stock Holding History

Jasper Ridge Partners’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.51M	Hold	39,457	–	–	0.03%	86
2026 Q1	$838K	Hold	39,457	–	–	0.02%	93
2025 Q4	$644K	Hold	39,457	–	–	0.01%	98
2025 Q3	$461K	Hold	39,457	–	–	0.01%	112
2025 Q2	$457K	Hold	39,457	–	–	0.01%	106
2025 Q1	$344K	Hold	39,457	–	–	0.01%	112
2024 Q4	$567K	Hold	39,457	–	–	0.02%	99
2024 Q3	$891K	Hold	39,457	–	–	0.03%	92
2024 Q2	$767K	Hold	39,457	–	–	0.02%	96
2024 Q1	$1.48M	Hold	39,457	–	–	0.05%	85
2023 Q4	$2.21M	Hold	39,457	–	–	0.09%	65
2023 Q3	$1.63M	Buy	39,457 +3,206	+9%	+$167K	0.08%	70
2023 Q2	$2.02M	Sell	36,251 -8,533	-19%	-$462K	0.1%	63
2023 Q1	$2.5M	Buy	44,784 +12,426	+38%	+$580K	0.12%	56
2022 Q4	$1.18M	Hold	32,358	–	–	0.07%	70
2022 Q3	$922K	Hold	32,358	–	–	0.06%	84
2022 Q2	$1.46M	Buy	32,358 +3,435	+12%	+$178K	0.09%	72
2022 Q1	$2.2M	Buy	28,923 +3,294	+13%	+$288K	0.11%	71
2021 Q4	$3.82M	Buy	25,629 +2,196	+9%	+$336K	0.14%	61
2021 Q3	$3.41M	Hold	23,433	–	–	0.15%	65
2021 Q2	$4.59M	Buy	23,433 +2,544	+12%	+$460K	0.23%	53
2021 Q1	$3.78M	Buy	20,889 +6,956	+50%	+$1.2M	0.17%	50
2020 Q4	$1.97M	Buy	13,933 +200	+1%	+$29K	0.09%	63
2020 Q3	$1.71M	Buy	13,733 +6,289	+84%	+$660K	0.1%	59
2020 Q2	$665K	Buy	+7,444	New	+$580K	0.05%	77

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jasper Ridge Partners's TXG Position: Q2 2026 in Review

Jasper Ridge Partners held its 10x Genomics (TXG) position steady in Q2 2026 at 39,457 shares worth $1.51M. The position accounts for 0.03% of the portfolio, ranked #86.

Jasper Ridge Partners first reported a position in TXG in Q2 2020 and has held it in 25 quarters since. The position peaked at $4.59M in Q2 2021. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

Jasper Ridge Partners held 39,457 shares of 10x Genomics worth $1.51M as of Q2 2026.
Jasper Ridge Partners left its 10x Genomics share count unchanged in Q2 2026.
10x Genomics made up 0.03% of Jasper Ridge Partners's portfolio in Q2 2026, its #86 holding.
Jasper Ridge Partners first reported a position in 10x Genomics in Q2 2020 and has held it in 25 quarters since.
Jasper Ridge Partners's 10x Genomics position peaked at $4.59M in Q2 2021.
390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Jasper Ridge Partners's 13F filing for Q2 2026, filed 13 Aug 2026.